First Time Loading...

Fate Therapeutics Inc
NASDAQ:FATE

Watchlist Manager
Fate Therapeutics Inc Logo
Fate Therapeutics Inc
NASDAQ:FATE
Watchlist
Price: 4.15 USD 1.72% Market Closed
Updated: May 14, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

506.2m
-7%
Assets
Growth Rates:
1 Year
-28%
3 Years
-19%
5 Years
+138%
7 Years
+433%
10 Years
+810%
137.8m
-2%
Liabilities
Growth Rates:
1 Year
-38%
3 Years
-42%
5 Years
+162%
7 Years
+529%
10 Years
+2 832%
368.4m
-9%
Equity
Growth Rates:
1 Year
-24%
3 Years
-4%
5 Years
+130%
7 Years
+403%
10 Years
+625%

Balance Sheet Decomposition
Fate Therapeutics Inc

506.2m
Assets
137.8m
Liabilities
506.2m
Assets
137.8m
Liabilities
Current Assets 331.5m
Cash & Short-Term Investments 315.2m
Receivables 1.8m
Other Current Assets 14.5m
Non-Current Assets 174.7m
Long-Term Investments 980k
PP&E 158.5m
Other Non-Current Assets 15.2m
Current Liabilities 39.1m
Accounts Payable 4.7m
Accrued Liabilities 33.7m
Other Current Liabilities 685k
Non-Current Liabilities 98.7m
Other Non-Current Liabilities 98.7m

Balance Sheet
Fate Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
49
65
89
89
191
100
167
134
61
42
Cash Equivalents
49
65
89
89
191
100
167
134
61
42
Short-Term Investments
0
0
4
12
11
122
316
482
375
273
Total Receivables
0
0
0
0
1
0
6
9
39
2
Accounts Receivables
0
0
0
0
1
0
6
9
39
2
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
1
1
1
2
4
6
6
9
27
15
Total Current Assets
50
66
93
103
205
227
494
633
502
332
PP&E Net
1
2
2
3
5
34
99
162
176
159
PP&E Gross
0
2
2
3
5
34
99
162
176
159
Accumulated Depreciation
0
4
4
5
6
9
11
17
30
48
Note Receivable
0
0
0
0
2
1
14
10
7
0
Long-Term Investments
0
0
0
0
0
39
0
101
5
1
Other Long-Term Assets
0
0
0
0
1
0
15
15
15
15
Total Assets
51
N/A
68
+33%
95
+40%
105
+11%
213
+102%
302
+42%
623
+106%
922
+48%
706
-23%
506
-28%
Liabilities
Accounts Payable
1
1
1
2
4
6
6
9
8
5
Accrued Liabilities
2
2
4
7
11
16
19
48
60
34
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
8
8
0
2
0
0
0
0
0
Other Current Liabilities
0
3
2
2
10
6
60
25
46
1
Total Current Liabilities
5
13
15
11
27
28
86
81
114
39
Long-Term Debt
18
11
3
15
12
0
0
0
0
0
Other Liabilities
0
6
4
2
13
30
152
161
108
99
Total Liabilities
23
N/A
30
+31%
22
-27%
28
+28%
53
+87%
58
+9%
238
+314%
243
+2%
222
-9%
138
-38%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
112
142
176
219
285
384
557
769
1 051
1 212
Additional Paid In Capital
141
180
249
296
446
628
941
1 449
1 537
1 580
Other Equity
0
0
0
0
0
0
0
1
2
0
Total Equity
28
N/A
38
+34%
73
+93%
77
+5%
161
+108%
245
+53%
384
+57%
679
+77%
484
-29%
368
-24%
Total Liabilities & Equity
51
N/A
68
+33%
95
+40%
105
+11%
213
+102%
302
+42%
623
+106%
922
+48%
706
-23%
506
-28%
Shares Outstanding
Common Shares Outstanding
21
29
41
53
65
76
88
96
97
99
Preferred Shares Outstanding
0
0
0
0
0
3
3
3
3
3

See Also

Summary
FATE intrinsic value, competitors valuation, and company profile.
DCF Valuation
FATE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FATE stock valuation using valuation multiples.
Wall Street Estimates
FATE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FATE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.